unknown
Stage
1
Investors
About
Genomill develops Geno1® library-prep technologies (including Bridge Capture™ and Nicking Loop™) for next-generation sequencing, offering a rapid, ultra-sensitive, PCR-free, and low-cost workflow aimed at diagnostics and targeted sequencing applications such as early cancer detection and MRD monitoring.
Explore Genomill's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.